“…5While CPM reduces the risk of developing a contralateral breast cancer, for most women (eg, those without a BRCA1 or BRCA2 mutation), this risk is relatively low, with the 5-year risk estimated to be <5%.Furthermore, there is no evidence that CPM improves survival 2,3 ; thus, this procedure is of limited medical benefit for most women.The socio-demographic, clinical, and psychological contributors to CPM have been well established, 6-8 and prior research has also highlighted the relationship between patient-driven decision making and CPM. 5,9,10 As breast cancer treatment can profoundly impact quality of life, understanding how and why young women make certain decisions about surgery, including undergoing CPM, can have important implications. Young breast cancer survivors often contend with unique issues due to their life stage, including fertility, breastfeeding, and caring for young children, when making these choices.…”